Related Experiment Video

Updated: May 30, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

C-Reactive protein predicts acute myocardial infarction during high-risk noncardiac and vascular surgery

Oscar M Martins1, Vicente F Fonseca, Ivan Borges

  • 1Instituto de Cardiologia do Rio Grande do Sul/FUC, Porto Alegre, RS, Brazil. oscar_morency@terra.com.br

Clinics (Sao Paulo, Brazil)
|July 27, 2011
PubMed

Insights

Elevated high-sensitivity C-reactive protein (hs-CRP) levels predict a higher risk of perioperative acute myocardial infarction in patients undergoing high-risk noncardiac surgery. This risk is particularly pronounced in vascular surgery patients with elevated baseline hs-CRP.

Area of Science:

  • Cardiology
  • Surgical Risk Assessment

Background:

  • High-sensitivity C-reactive protein (hs-CRP) is a known predictor of cardiovascular events.
  • Its role in predicting perioperative acute myocardial infarction (AMI) during noncardiac surgery remains unclear.
  • This study aimed to clarify hs-CRP's predictive value for AMI in this context.

Purpose of the Study:

  • To investigate high-sensitivity C-reactive protein (hs-CRP) levels as predictors of acute myocardial infarction (AMI) risk.
  • To assess AMI risk in patients undergoing high-risk noncardiac surgery.
  • To specifically evaluate the association in vascular surgery patients.

Main Methods:

  • A concurrent cohort study included 101 patients aged ≥50 years undergoing high-risk noncardiac surgery.
  • Exclusion criteria included infections.
  • Baseline hs-CRP levels were measured and compared between patients who did and did not experience perioperative AMI, with cardiac biomarkers assessed post-surgery.

Main Results:

  • Baseline hs-CRP levels were significantly higher in patients who experienced perioperative AMI (mean 48.02) compared to those who did not (mean 4.50, p=0.005).
  • All five AMI cases occurred in vascular surgery patients with elevated baseline hs-CRP.
  • The study included 33 vascular procedures (17 aortic, 16 peripheral artery revascularizations).

Conclusions:

  • Elevated baseline high-sensitivity C-reactive protein (hs-CRP) levels identify patients at increased risk for perioperative acute myocardial infarction (AMI).
  • This risk is particularly significant for patients undergoing high-risk noncardiac surgery, especially vascular procedures.
  • hs-CRP may serve as a valuable biomarker for risk stratification in this population.
Abstract

More Related Videos

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia07:25

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease04:41

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease

Published on: July 3, 2018

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...